BioSpace News Archive

Bio NC

Agios Announces Pricing of $475M Public Offering of Common Stock

Closing of the offering is expected to occur on or about January 23, 2018, subject to customary closing conditions.

January 19, 2018
·
4 min read
BioCapital

Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters

Intrexon sold 6,900,000 shares of its common stock at a public offering price of $12.50 per share, including the exercise in full by the underwriters of their option to purchase an additional 900,000 shares of common stock.

January 19, 2018
·
3 min read
Business

AIT Bioscience Welcomes New Scientist, Jim Eckstein

AIT Bioscience welcomes Jim Eckstein to our scientific ranks. Jim brings more than 20 years of experience in LC/MS analysis, including the analysis of small molecule pharmaceuticals, biomarkers, as well as peptide and protein biotherapeutics.

January 19, 2018
·
1 min read
Pharm Country

First-Time Data for Merck’s KEYTRUDA (pembrolizumab) in Patients with Previously Treated Advanced Hepatocellular Carcinoma (HCC) to be Presented at 2018 ASCO GI Symposium

Merck today announced findings from the registrational phase 2 KEYNOTE-224 trial investigating the use of KEYTRUDA (pembrolizumab).

January 19, 2018
·
26 min read
Oramed Pharma’s CEO Issues Letter to Shareholders

2017 Major Milestones Achieved

January 19, 2018
·
6 min read
Pharm Country

Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma

Results from the IIR support the findings of the investigator review per mRECIST, confirming lenvatinib demonstrated statistically significant and clinically meaningful improvements across all secondary efficacy endpoints.

January 19, 2018
·
16 min read
Policy

Locate Therapeutics Successfully Achieves ISO 13845 Certification for Design, Development and Control of Manufacture for Resorbable Biomaterials

Locate Therapeutics has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration.

January 19, 2018
·
2 min read
Business

UPM Pharma Appoints Chris Curtin as COO

Mr. Curtin was promoted from his previous role as Executive VP of Quality Operations.

January 19, 2018
·
2 min read
Business

Zealand Pharma Strengthens Its Management by Appointing Ivan Møller as SVP, Technical Development & Operations

Ivan Møller is joining Zealand as a new member of Management with effect from March 1, 2018.

January 19, 2018
·
2 min read
Policy

Santhera Plans to Announce Regulatory Feedback for Raxone in DMD and 2017 Preliminary Key Financial Figures

Santhera expects to receive an opinion by the CHMP of the EMA for its MAA filed as Type II extension application for Raxone in DMD by January 26.

January 19, 2018
·
3 min read